Assessing the value of nivolumab (NIVO) versus placebo (PBO) and ipilimumab (IPI) as adjuvant therapy for resected melanoma Meeting Abstract
| Authors: | Freeman, M. L.; Shoushtari, A. N.; Betts, K. A.; Gupte-Singh, K.; Du, E. X.; Ritchings, C.; Rao, S. |
| Abstract Title: | Assessing the value of nivolumab (NIVO) versus placebo (PBO) and ipilimumab (IPI) as adjuvant therapy for resected melanoma |
| Meeting Title: | 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2018 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-05-20 |
| Start Page: | 512s |
| Language: | English |
| ACCESSION: | WOS:000442916003367 |
| DOI: | 10.1200/JCO.2018.36.15_suppl.9594 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 9594 -- Source: Wos |
